122 related articles for article (PubMed ID: 27067917)
1. Structure-activity relationships of phthalates in inhibition of human placental 3β-hydroxysteroid dehydrogenase 1 and aromatase.
Xu RA; Mao B; Li S; Liu J; Li X; Li H; Su Y; Hu G; Lian QQ; Ge RS
Reprod Toxicol; 2016 Jun; 61():151-61. PubMed ID: 27067917
[TBL] [Abstract][Full Text] [Related]
2. Effects of Methoxychlor and Its Metabolite Hydroxychlor on Human Placental 3β-Hydroxysteroid Dehydrogenase 1 and Aromatase in JEG-3 Cells.
Liu S; Mao B; Bai Y; Liu J; Li H; Li X; Lian Q; Ge RS
Pharmacology; 2016; 97(3-4):126-33. PubMed ID: 26735933
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Fungicides on Human 3β-Hydroxysteroid Dehydrogenase 1 and Aromatase in Human Placental Cell Line JEG-3.
Cao S; Ye L; Wu Y; Mao B; Chen L; Wang X; Huang P; Su Y; Ge RS
Pharmacology; 2017; 100(3-4):139-147. PubMed ID: 28637041
[TBL] [Abstract][Full Text] [Related]
4. Gossypol enantiomers potently inhibit human placental 3β-hydroxysteroid dehydrogenase 1 and aromatase activities.
Dong Y; Mao B; Li L; Guan H; Su Y; Li X; Lian Q; Huang P; Ge RS
Fitoterapia; 2016 Mar; 109():132-7. PubMed ID: 26709042
[TBL] [Abstract][Full Text] [Related]
5. Chemicals of environmental concern as inhibitors of human placental 3β-hydroxysteroid dehydrogenase 1 and aromatase: Screening and docking analysis.
Tang L; Shi L; Tang Y; Ying Y; Dong Y; Li H; Ge RS
Chem Biol Interact; 2022 Dec; 368():110243. PubMed ID: 36374910
[TBL] [Abstract][Full Text] [Related]
6. Human placental 3β-hydroxysteroid dehydrogenase/steroid Δ5,4-isomerase 1: Identity, regulation and environmental inhibitors.
Zhu Q; Pan P; Chen X; Wang Y; Zhang S; Mo J; Li X; Ge RS
Toxicology; 2019 Sep; 425():152253. PubMed ID: 31351905
[TBL] [Abstract][Full Text] [Related]
7. Ziram inhibits aromatase activity in human placenta and JEG-3 cell line.
Chen L; Chen X; Chen X; Hu Z; Li X; Su Y; Li X; Ge RS
Steroids; 2017 Dec; 128():114-119. PubMed ID: 28951168
[TBL] [Abstract][Full Text] [Related]
8. Effects of phthalates on 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase 3 activities in human and rat testes.
Yuan K; Zhao B; Li XW; Hu GX; Su Y; Chu Y; Akingbemi BT; Lian QQ; Ge RS
Chem Biol Interact; 2012 Feb; 195(3):180-8. PubMed ID: 22214983
[TBL] [Abstract][Full Text] [Related]
9. Effect of ketoconazole on placental aromatase, 3 beta-hydroxysteroid dehydrogenase-isomerase and 17 beta-hydroxysteroid dehydrogenase.
Ayub M; Stitch SR
J Steroid Biochem; 1986 Dec; 25(6):981-4. PubMed ID: 3025521
[TBL] [Abstract][Full Text] [Related]
10. Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status.
Chang YC; Chen CK; Chen MJ; Lin JC; Lin CH; Huang WC; Cheng SP; Chen SN; Liu CL
Ann Surg Oncol; 2017 Dec; 24(13):4033-4041. PubMed ID: 28744792
[TBL] [Abstract][Full Text] [Related]
11. 3 beta-hydroxysteroid dehydrogenase isomerase (3beta-HSD) activity in the rat sciatic nerve: kinetic analysis and regulation by steroids.
Coirini H; Gouézou M; Delespierre B; Schumacher M; Guennoun R
J Steroid Biochem Mol Biol; 2003 May; 85(1):89-94. PubMed ID: 12798361
[TBL] [Abstract][Full Text] [Related]
12. Structure-dependent inhibition of human and rat 11beta-hydroxysteroid dehydrogenase 2 activities by phthalates.
Zhao B; Chu Y; Huang Y; Hardy DO; Lin S; Ge RS
Chem Biol Interact; 2010 Jan; 183(1):79-84. PubMed ID: 19786001
[TBL] [Abstract][Full Text] [Related]
13. Trilostane, a 3β-hydroxysteroid dehydrogenase inhibitor, suppresses growth of hepatocellular carcinoma and enhances anti-cancer effects of sorafenib.
Lin JC; Liu CL; Chang YC; Cheng SP; Huang WC; Lin CH; Wu CY; Chen MJ
Invest New Drugs; 2021 Dec; 39(6):1493-1506. PubMed ID: 34031786
[TBL] [Abstract][Full Text] [Related]
14. Endometrial Intracrinology--generation of an estrogen-dominated microenvironment in the secretory phase of women.
Gibson DA; McInnes KJ; Critchley HO; Saunders PT
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1802-6. PubMed ID: 24014622
[TBL] [Abstract][Full Text] [Related]
15. Endocrine disruptors of inhibiting testicular 3β-hydroxysteroid dehydrogenase.
Zhang S; Mo J; Wang Y; Ni C; Li X; Zhu Q; Ge RS
Chem Biol Interact; 2019 Apr; 303():90-97. PubMed ID: 30826252
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 1 Suppresses Interleukin-6 in Breast Cancer.
Chang YC; Lin CH; Lin JC; Cheng SP; Chen SN; Liu CL
J Surg Res; 2019 Sep; 241():8-14. PubMed ID: 31004874
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human placental progesterone synthesis in vitro by naturally occurring steroids.
Rabe T; Kiesel L; Runnebaum B
J Steroid Biochem; 1985 May; 22(5):657-64. PubMed ID: 3859707
[TBL] [Abstract][Full Text] [Related]
18. Bovine adrenal 3beta-hydroxysteroid dehydrogenase (E.C. 1.1.1. 145)/5-ene-4-ene isomerase (E.C. 5.3.3.1): characterization and its inhibition by isoflavones.
Wong CK; Keung WM
J Steroid Biochem Mol Biol; 1999 Dec; 71(5-6):191-202. PubMed ID: 10704908
[TBL] [Abstract][Full Text] [Related]
19. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
[TBL] [Abstract][Full Text] [Related]
20. The effects of aflatoxin B1 on transporters and steroid metabolizing enzymes in JEG-3 cells.
Huuskonen P; Myllynen P; Storvik M; Pasanen M
Toxicol Lett; 2013 Apr; 218(3):200-6. PubMed ID: 23402939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
